
Network Bio
- Network Bio just raised $50M (Series A) on Aug 19
Leveraging AI and a massive patient tissue dataset to accelerate drug discovery and advance precision medicine.
About
Network Bio is a biotechnology company building disease-specific AI models from human biological data to support the personalized practice of medicine. They utilize artificial intelligence and a research network of leading U.S. academic biobanks to create the world's largest patient tissue training dataset, linked to blood samples and clinical outcomes.
Show 6 more similar companies
Similar companies
Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.
Shares Biotechnology, Biotech
Epicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).
Shares Biotechnology, Biotech
A life sciences company that has developed a high-throughput platform for mapping molecular cell architecture at nanoscale resolution.
Shares Biotechnology, Genomics
Freenome is a biotechnology company developing a multi-cancer early detection blood test using machine learning and biology.
Shares Biotechnology, Healthcare
A vertically-integrated procurement platform for the life sciences industry.
Shares Biotechnology, Biotech
Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.
Shares Biotechnology, Artificial Intelligence
Signals agent
Reach companies that have budget right now
Every week the agent finds companies in your market that just got money or started hiring to spend it, and the person to talk to. You choose who to reach; nothing is sent for you.
- Just raised a roundFresh budget, the week it lands
- Hiring sales and marketingGo-to-market roles mean money to spend
- Hiring fastA jump in open roles across the company
- In the newsLaunches and announcements worth a message
- The decision makerWho to contact, with a message you can edit
Is your startup an alternative to Network Bio?
People comparing tools land here. Get listed beside these.
Copy Network Bio's SEO strategy
How often they publish, which searches their posts chase and their newest posts. Then outrank them.
All funding rounds
Key facts
- Website
- networkbio.com
- Headquarters
- Palo Alto, United States
- Founded
- 2023
- Founders
- Raphael Potter, Hani Goodarzi
- Employees
- 24
- Total funding
- $50M (Series A)
- Business model
- B2B
Funding rounds
- $50M19 Aug 2026
Led by Section 32, Thiel Bio
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 19 Aug 2026 | Series A | $50M | Section 32, Thiel Bio |
Tech stack
Detected on networkbio.com, last scanned 4 Nov 2026. Run your own scan
- Hosting
- Linode (Akamai)
Measured, not editorial
Agent Readiness
Bottom 25%
Scan yoursSite Speed
Below median
PageSpeedData Trust
Below median
Security
Click to scan
Agent Readiness
Can AI agents use your site?
Network Bio scores 21. Check yours free in a few seconds, or let Max Agent rerun it daily.
Run it daily with Max AgentGet notified when Network Bio changes
Used Network Bio? Write a review and get $5 in credits
Your first review on StartupHub.ai adds 1,250 credits to your account. Spend them on:
- Email finder
- Market Map Maker
- Agent Readiness scans
- Deep intel
- Tech stack scans
How people find Network Bio on Google
Searches that showed this page, last 28 days
- biotech startup jobs$$$5 seen#79
- network bio$$$1 seen#16
- network bio funding$$$1 seen#35
$$$ high buyer intent (pricing, reviews, alternatives), $$ brand searches, $ research. Read from the wording, not ad prices.
Frequently asked
Is Network Bio growing?
Yes, fast. Our data shows it raised $50M in a Series A in August 2026.
Who owns Network Bio?
Network Bio is privately held, owned by its founders and investors. Investors on record include Section 32, Thiel Bio, Founders Fund and Breyer Capital. Exact stakes are not public.
Are there companies like Network Bio?
Yes. We list 6 companies like Network Bio, including Moderna, Epicrispr Biotechnologies and Pixelgen Technologies.
What does Network Bio do?
Their platform centralizes research-grade data assets, serving as a neutral broker between healthcare institutions and industry partners to enable sophisticated research and development and facilitate biomedical discoveries.
Is Network Bio trustworthy and reputable?
StartupHub's Data Trust & Reputation score for Network Bio is 53 out of 100, a use-caution rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.
How much funding has Network Bio raised?
Network Bio has raised a total of $50M in funding. The most recent round on record is Series A.
How many employees does Network Bio have?
Network Bio has approximately 24 people on record.
SEC filings, insider activity, nonprofit links and pay benchmarks for Network Bio:
Company details: from public sources. Funding: 1 round on file. Ownership: not yet claimed by the company. Scores: measured by named tools; each links to its method. Our rules
Categories
Max Agent
Let Max Agent watch Network Bio and its market for you
New competitors, funding rounds, pricing and product changes, and where you show up in AI answers, in one weekly report.
Free week
Starter listings, once
AI answers checked
Daily for 7 days
ChatGPT
Perplexity
Max Agent
$79 a month, or $9.99 with our badge on your site
AI answers checked
Every week
ChatGPT
Claude
Perplexity
Gemini

